Table 5.
Various Indian biopharmaceutical companies engaged in COVID-19 vaccines development and manufacturing (https://covid19.trackvaccines.org/country/india/, 9 October 2022).
| Vaccines | Indian Manufacturer | Collaborator(s) | Current Regulatory Status |
|---|---|---|---|
| Covishield | Serum Institute of India, Pune, India | Oxford-AstraZeneca | Approved |
| Covaxin | BharatBiotech Int. Ltd., Hyderabad, India | Indian Council of Medical Research, National Institute of Virology | Approved |
| ZyCov-D | Cadila Healthcare Ltd., Ahmedabad, India | Department of Biotechnology, India | Approved |
| Sputinik V | Dr. Reddy’s lab, Hyderabad, India | Gamaleya National Centre, Russia | Approved |
| NCV-COV2373 | Serum Institute of India, Pune | Novovax | Emergency authorisation |
| HGCO 19 m-RNA based vaccine | Genova, Pune, India | HDT-Bio, US DBT |
Approved |
| Recombinant protein-based Vaccine (Corbevax) | Biological E, Hyderabad, India | Baylor College, US | Approved |
| Codon-deoptimised live attenuated COVID-19 Vaccine |
Indian Immunologicals Limited, India | Griffith University, Australia | Pre-clinical |
| Warm COVID-19 Vaccine | Mynvax, Indian institute of Science, Bengaluru, India | BIRAC |